BNCT for Thoracic Malignant Tumor – Submission of Trial Plan Notification for Domestic Clinical Trial Phase I/II
We would like to announce that our company submitted the trial plan notificatio……
We would like to announce that our company submitted the trial plan notificatio……
A paper containing the treatment results of unresectable, locally recurrent or ……
Together with China Biotech Services Holdings Limited (CBSH), our partner for t……
Our company provides Steboronine® for the investigator-initiated specified clin……
The international science journal “Nature” published in its special edition “Ra……
Our company provides the boron drug for BNCT (Boron Neutron Capture Therapy), w……
The results regarding safety and effectiveness of our product Borofalan(10B), u……
We would like to announce that Phase I clinical trial for newly diagnosed gliob……
Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……
Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……
Business France Japan Office of the French Embassy in Japan engages in building……
On 25th September, the Groundbreaking Ceremony for the Boao BNCT center has tak……